+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis



Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis



Cancer Biomarkers 16(3): 415-423



Lactare dehydrogenase (LDH) has been proven to be a prognostic and a potential pro-tumor factor in patients with lung cancer. But the prognostic value of serum LDH in small cell lung cancer (SCLC) has not been quantified systematically. Thus, this study was to evaluate the correlations between serum LDH and overall survival of SLCLC by systematic review with meta-analysis. PubMed, EMBASE, Cochrane Library, Web of Science databases were searched from inception to October 2014 and references in those publications would be included if the association between serum LDH and overall survival of SCLC can be derived. Quality assessment and data extraction were performed in the articles selected according to inclusion and exclusion criteria. Twenty-eight studies including 4785 patients with SCLC were deemed eligible. Pooled results showed that SCLC patients with elevated LDH levels were associated with an increased hazard ratio (HR 1.45, 95%CI 1.27∼ 1.66) of overall survival. The study suggests significant correlations between elevated serum LDH levels and poor overall survival in patients with SCLC. And serum LDH levels can be measured combining with other tools for assessing the risk stratification and prognosis of SCLC, which shows directions for treatments of SCLC.

(PDF emailed within 0-6 h: $19.90)

Accession: 058637314

Download citation: RISBibTeXText

PMID: 27062698

DOI: 10.3233/CBM-160580


Related references

Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. Journal of Thoracic Disease 8(7): 1587-1600, 2016

Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget 7(14): 18458-18468, 2017

Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis. Oncotarget 7(24): 36065-36073, 2016

Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. Clinical and Experimental Medicine 17(2): 161-174, 2016

Prognostic and predictive significance of thymidylate synthase protein expression in non-small cell lung cancer: a systematic review and meta-analysis. Cancer Biomarkers 15(1): 65-78, 2015

Clinicopathological and prognostic significance of heat shock protein 27 (HSP27) expression in non-small cell lung cancer: a systematic review and meta-analysis. Springerplus 5(1): 1165, 2016

Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis. International Journal of Biological Markers 33(4): 372-378, 2018

Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis. Lung Cancer 81(1): 1-10, 2014

The prognostic value of metformin for advanced non-small cell lung cancer: a systematic review and meta-analysis. Translational Lung Cancer Research 7(3): 389-396, 2018

Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Clinical Laboratory 62(11): 2203-2211, 2017

Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. Journal of Thoracic Disease 5(1): 40-47, 2013

Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis. Tumour Biology 35(10): 10105-10110, 2015

Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis. Medicine 98(16): E15069, 2019

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis. Cancer Management and Research 10: 3393-3404, 2018

Prognostic role of ERCC1 in advanced non-small-cell lung cancer: a systematic review and meta-analysis. Clinical Lung Cancer 12(6): 393-401, 2012